| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |